Efficacy and safety of immune checkpoint inhibitors in patients with non‐small cell lung cancer aged 80 years or older-Reference-Cited by-同舟云学术

Efficacy and safety of immune checkpoint inhibitors in patients with non‐small cell lung cancer aged 80 years or older

Published:2021-05-02 Issue:6 Volume:4 Page:
ISSN:2573-8348
Container-title:Cancer Reports
language:en
Short-container-title:Cancer Reports

Author:

Saito Zentaro¹,Fujita Kohei¹^ORCID,Okamura Misato¹,Ito Takanori¹,Yamamoto Yuki¹²,Kanai Osamu¹^ORCID,Hashimoto Masayuki³,Nakatani Koichi¹,Sawai Satoru³,Mio Tadashi¹

Affiliation:

1. Division of Respiratory Medicine, Center for Respiratory Diseases National Hospital Organization Kyoto Medical Center Kyoto Japan

2. Department of Drug Discovery for Lung Diseases, Graduate School of Medicine Kyoto University Kyoto Japan

3. Division of Thoracic Surgery, Center for Respiratory Diseases National Hospital Organization Kyoto Medical Center Kyoto Japan

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cnr2.1405

Reference19 articles.

1. The checkpoint immunotherapy revolution: what started as a trickle has become a flood, despite some daunting adverse effects; new drugs, indications, and combinations continue to emerge;Alexander W;P T,2016

2. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

3. Characteristics of Real-World Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab and Pembrolizumab During the Year Following Approval

4. The effectiveness of PD-1 inhibitors in non-small cell lung cancer (NSCLC) patients of different ages

5. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone marrow biopsy in geriatric patients above the age of 85 years: invaluable or unnecessary? A retrospective analysis;Annals of Hematology;2024-02-10

2. Safety of flexible bronchoscopy and clinical course for elderly patients with suspected primary lung cancer;Thoracic Cancer;2024-01-28

3. Safety and Efficacy of Flexible Bronchoscopy in Elderly Patients: A Retrospective Comparative Study;Open Respiratory Archives;2023-10

4. Immunotherapy in Elderly Patients Affected by Non-Small Cell Lung Cancer: A Narrative Review;Journal of Clinical Medicine;2023-02-24

5. Immune Checkpoint Inhibitors in Lung Cancer;Highlights in Science, Engineering and Technology;2022-08-17